G. Evans

发表

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Susan L Neuhausen, Olufunmilayo I Olopade, Judy E Garber, 2002, The New England journal of medicine.

Low prevalence of germlineBRCA1 mutations in early onset breast cancer without a family history

C. Mathew, S. McCall, S. Hodgson, 2000, Journal of medical genetics.

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

F. Couch, O. Olopade, J. Klijn, 2002, Journal of the National Cancer Institute.

Molecular genetics and endometrial cancer.

F. Lalloo, G. Evans, 2001, Best practice & research. Clinical obstetrics & gynaecology.

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Susan L Neuhausen, Olufunmilayo I Olopade, Judy E Garber, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

F. Couch, O. Olopade, J. Klijn, 2002, Journal of the National Cancer Institute.

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes

E. Schröck, C. Lázaro, G. Capellá, 2018, Familial Cancer.

Jews . mutations in a population of Ashkenazi An evaluation of common breast cancer gene

A. Howell, J. Varley, S. Cochrane, 2022 .

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

E. Schröck, C. Lázaro, G. Capellá, 2020, European Journal of Human Genetics.

Title Interplay between BRCA 1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Loris, Fiona, Meindl, 2012 .

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

J. Chang-Claude, J. Benítez, D. Easton, 2006, Journal of the National Cancer Institute.

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

E. Schröck, C. Lázaro, G. Capellá, 2020, European Journal of Human Genetics.

Development of a scoring system to screen for BRCA1/2 mutations.

F. Lalloo, G. Evans, 2010, Methods in molecular biology.

The Fanconi anemia group E gene, FANCE, maps to chromosome 6p.

C. Mathew, Q. Waisfisz, R. Wegner, 1999, American journal of human genetics.

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

O. Olopade, T. Rebbeck, R. Eeles, 2006, The Lancet. Oncology.

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Marc Vidal, Dieter Niederacher, Roderic Guigó, 2011, PLoS biology.

Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

J. Chang-Claude, D. Easton, A. Antoniou, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers

T. Rebbeck, B. Weber, J. Garber, 2004 .

Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer.

Julian Peto, Sergi Castellví-Bel, Jean-Baptiste Cazier, 2008, Human molecular genetics.

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

S. Rosset, W. He, S. Cross, 2023, Journal of Medical Genetics.

The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.

B. Ponder, D. Easton, M. Gore, 1999, American journal of human genetics.

Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.

D. Easton, S. Mazoyer, R. Dicioccio, 1994, American journal of human genetics.

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

A. Howell, D. Evans, A. Shenton, 2008, BMC Cancer.

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

E A Jones, A Howell, A. Howell, 2009, Journal of Medical Genetics.

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

J. Chang-Claude, J. Benítez, D. Easton, 2006, Journal of the National Cancer Institute.

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

F. Couch, O. Olopade, J. Klijn, 2002, Journal of the National Cancer Institute.